ASTANA, Kazakhstan, March 28. Kazakhstan and
India discussed ways to deepen bilateral cooperation in the
pharmaceutical sector, Trend reports via the Kazakh MFA
The talks were held during the Kazakhstan-India Pharma Business
Meeting, held in New-Delhi on March 28.
The meeting brought together Kazakh government officials,
including Deputy Minister of Foreign Affairs Alibek Kuantyrov, and
representatives of leading Indian pharmaceutical companies, such as
Acies Pharmaceutical Pvt. Ltd., Abaris Healthcare Pvt. Ltd., Akriti
Pharmaceuticals Pvt Ltd., and AMTEC Health Care Pvt Ltd. The event
aimed to enhance economic ties and promote joint investment
projects in the industry.
At the forum, Kuantyrov highlighted that over 12,000 Indian
students are currently studying in Kazakhstan, most of them in
medical universities, which lays a strong foundation for future
collaboration in healthcare and medical research. He also cited the
recent investment by India’s MSN Group to build a full-cycle
pharmaceutical plant in the Almaty region as an example of growing
business engagement.
The Mayor of Kazakhstan's Almaty Darkhan Satibaldy praised the
city’s development of modern pharmaceutical clusters, scientific
centers, and new drug production projects. Indian Ambassador to
Kazakhstan Sailas Tangal emphasized the importance of the forum in
fostering long-term economic relations between the two
countries.
The event also featured a presentation by JSC NC Kazakh Invest
on Kazakhstan’s investment and pharmaceutical potential, inviting
Indian investors to actively participate in localizing drug and
medical equipment production in the country.
